| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | AGK |
| Uniprot No | Q53H12 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-422aa |
| 氨基酸序列 | MTVFFKTLRNHWKKTTAGLCLLTWGGHWLYGKHCDNLLRRAACQEAQVFGNQLIPPNAQVKKATVFLNPAACKGKARTLFEKNAAPILHLSGMDVTIVKTDYEGQAKKLLELMENTDVIIVAGGDGTLQEVVTGVLRRTDEATFSKIPIGFIPLGETSSLSHTLFAESGNKVQHITDATLAIVKGETVPLDVLQIKGEKEQPVFAMTGLRWGSFRDAGVKVSKYWYLGPLKIKAAHFFSTLKEWPQTHQASISYTGPTERPPNEPEETPVQRPSLYRRILRRLASYWAQPQDALSQEVSPEVWKDVQLSTIELSITTRNNQLDPTSKEDFLNICIEPDTISKGDFITIGSRKVRNPKLHVEGTECLQASQCTLLIPEGAGGSFSIDSEEYEAMPVEVKLLPRKLQFFCDPRKREQMLTSPTQ |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于AGK(Acylglycerol Kinase)重组蛋白的3篇代表性文献，涵盖其功能研究及重组表达技术：
1. **文献名称**: "Mitochondrial AGK regulates hepatocyte lipid metabolism via phosphorylation of phosphatidylglycerol"
**作者**: Li X, et al.
**摘要**: 本研究通过重组表达人源AGK蛋白，验证其在线粒体中对磷脂酰甘油的磷酸化作用，揭示AGK通过调控脂质代谢影响肝细胞能量稳态的分子机制。
2. **文献名称**: "Recombinant AGK expression in HEK293 cells and its role in apoptosis regulation"
**作者**: Wang Y, et al.
**摘要**: 利用HEK293细胞系统重组表达AGK蛋白，发现其通过激活线粒体途径调控细胞凋亡，为肿瘤治疗中靶向AGK的潜在应用提供依据。
3. **文献名称**: "Structural and enzymatic characterization of acylglycerol kinase from Drosophila melanogaster"
**作者**: Zhang Q, et al.
**摘要**: 首次报道果蝇AGK重组蛋白的晶体结构解析，阐明其底物结合域及催化活性关键位点，为开发特异性激酶抑制剂奠定结构基础。
注：以上文献信息为示例性概括，具体研究请通过PubMed/Google Scholar检索PMID进行验证。实际研究中建议优先选择近5年高被引论文或权威期刊文献。
**Background of AGK Recombinant Protein**
Acylglycerol kinase (AGK) is a mitochondrial enzyme involved in lipid metabolism and cellular energy homeostasis. It catalyzes the phosphorylation of monoacylglycerol (MAG) and diacylglycerol (DAG) to produce lysophosphatidic acid (LPA) and phosphatidic acid (PA), respectively. These lipid intermediates serve as signaling molecules and precursors for phospholipid synthesis, influencing processes such as membrane dynamics, apoptosis, and mitochondrial function. AGK’s role extends beyond metabolism; mutations in the *AGK* gene are linked to severe human disorders, including Sengers syndrome, characterized by cataracts, hypertrophic cardiomyopathy, and mitochondrial dysfunction.
Recombinant AGK protein is engineered to study its biochemical properties, structural interactions, and pathological mechanisms. Produced via heterologous expression systems (e.g., *E. coli* or mammalian cells), recombinant AGK retains enzymatic activity and enables in vitro analysis of substrate specificity, kinetics, and inhibitor screening. Its purification often involves affinity chromatography and tag-based strategies (e.g., His-tag) to ensure high yield and purity.
Research on AGK recombinant protein has advanced understanding of lipid-mediated signaling in metabolic diseases, cancer, and mitochondrial disorders. For instance, AGK overexpression in certain cancers correlates with altered lipid signaling and tumor progression, highlighting its potential as a therapeutic target. Structural studies using recombinant AGK have also elucidated mechanisms underlying pathogenic mutations, aiding drug design. However, challenges remain in maintaining protein stability and mimicking native post-translational modifications in vitro.
Overall, AGK recombinant protein serves as a critical tool for dissecting lipid metabolism pathways and developing targeted therapies for AGK-associated diseases. Its applications span basic research, diagnostic assay development, and preclinical drug discovery.
×
